ADC developer, Iksuda Therapeutics, closes $47m financing round 07-Jun-2021 By Jane Byrne UK-based biotechnology company, Iksuda Therapeutics, has completed a US$47m (£34m) financing round, which was led by Mirae Asset financial group and included a strategic investment from Korean biopharma player, Celltrion.
Chinese cell therapy player generates $300m in IPO 05-Nov-2020 By Jane Byrne China based CAR-T biotech, JW Therapeutics, has raised $300m in its IPO on the Hong Kong Stock Exchange.